Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-Phenyl-1,2-propandiol is an aromatic small molecule with the chemical formula C9H12O2 and a molecular weight of approximately 152.19. It consists of a benzene ring attached to a propane backbone bearing two hydroxyl groups at positions 1 and 2. The compound is classified as experimental and has not been approved for pharmaceutical use in any jurisdiction. Its primary mechanism of action is reported as inhibition of renin (Renin inhibitor), suggesting potential utility in modulating the renin–angiotensin system; however, there are no approved indications or clinical trials beyond preclinical/experimental stages[1][6][7]. No information on its pharmacokinetics or therapeutic applications in humans is available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-Phenyl-1,2-propandiol.